FFP
GILD icon

FourThought Financial Partners’s Gilead Sciences GILD Stock Holding History

FourThought Financial Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$432K Buy
3,418
+1,560
+84% +$206K 0.03% 220
2026
Q1 		$259K Buy
+1,858
New +$260K 0.02% 295

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FourThought Financial Partners's GILD Position: Q2 2026 in Review

FourThought Financial Partners increased its Gilead Sciences (GILD) stake by 84% in Q2 2026, buying an estimated $206K and bringing the position to 3,418 shares worth $432K. The position accounts for 0.03% of the portfolio, ranked #220.

FourThought Financial Partners first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • FourThought Financial Partners held 3,418 shares of Gilead Sciences worth $432K as of Q2 2026.
  • FourThought Financial Partners bought 1,560 Gilead Sciences shares in Q2 2026, an estimated $206K.
  • Gilead Sciences made up 0.03% of FourThought Financial Partners's portfolio in Q2 2026, its #220 holding.
  • FourThought Financial Partners first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on FourThought Financial Partners's 13F filing for Q2 2026, filed 12 Aug 2026.